Morgan Stanley
RNLX

Morgan Stanley’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Morgan Stanley’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,200
Closed -$460 – 8227
2024
Q3 		$460 Sell
2,200
-4,256
-66% -$1.36K ﹤0.01% 7309
2024
Q2 		$1.49K Buy
6,456
+3,433
+114% +$2.05K ﹤0.01% 7105
2024
Q1 		$2.6K Sell
3,023
-56,305
-95% -$38.6K ﹤0.01% 7026
2023
Q4 		$23.1K Buy
59,328
+26,398
+80% +$21.1K ﹤0.01% 6610
2023
Q3 		$52.7K Sell
32,930
-33,033
-50% -$91.2K ﹤0.01% 6149
2023
Q2 		$193K Buy
65,963
+3,150
+5% +$7.13K ﹤0.01% 5663
2023
Q1 		$152K Buy
62,813
+197
+0.3% +$546 ﹤0.01% 5831
2022
Q4 		$117K Buy
62,616
+623
+1% +$973 ﹤0.01% 5910
2022
Q3 		$79K Buy
61,993
+3,620
+6% +$7.88K ﹤0.01% 6198
2022
Q2 		$143K Buy
58,373
+41,691
+250% +$198K ﹤0.01% 6077
2022
Q1 		$116K Buy
16,682
+12,370
+287% +$131K ﹤0.01% 6230
2021
Q4 		$68K Sell
4,312
-16,206
-79% -$324K ﹤0.01% 6657
2021
Q3 		$411K Buy
20,518
+13,425
+189% +$346K ﹤0.01% 5615
2021
Q2 		$219K Buy
7,093
+5,220
+279% +$156K ﹤0.01% 5964
2021
Q1 		$48K Sell
1,873
-1,800
-49% -$45.1K ﹤0.01% 6374
2020
Q4 		$59K Buy
3,673
+2,000
+120% +$24.7K ﹤0.01% 6112
2020
Q3 		$20K Buy
+1,673
New +$24.2K ﹤0.01% 6071

Other funds holding RNLX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
IIC
Ironwood Investment Counsel Scottsdale, Arizona $694M AUM 16.84% 1-Year Est. Return

Morgan Stanley's RNLX Position: Q4 2024 in Review

Morgan Stanley sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 2,200 shares — an estimated $460 sold.

Morgan Stanley first reported a position in RNLX in Q3 2020 and held it in 17 quarters. The position peaked at $411K in Q3 2021. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

  • Morgan Stanley reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Morgan Stanley sold 2,200 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $460.
  • Morgan Stanley first reported a position in Renalytix plc American Depositary Shares in Q3 2020 and held it in 17 quarters.
  • Morgan Stanley's Renalytix plc American Depositary Shares position peaked at $411K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.